Avidity Partners Management LP / 2655787D
Avidity Partners Management LP’s Blueprint Medicines Position
Does Avidity Partners Management LP own Blueprint Medicines (2655787D)? Not currently — the last reported position was 68.5K shares worth $6M in Q1 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$6M
Q1 2025
Shares
68.5K
% of Portfolio
+1.16%
Quarters Held
14
position exited
Position History 2655787D
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2025 | 68.5K | $6M | +1.16% |
| Q4 2024 | 176.6K | $15M | +1.51% |
| Q3 2024 | 315.0K | $29M | +1.49% |
| Q2 2024 | 383.0K | $41M | +1.75% |
| Q1 2024 | 426.0K | $40M | +1.30% |
| Q4 2023 | 615.0K | $57M | +2.07% |
| Q3 2023 | 751.6K | $38M | +1.52% |
| Q2 2023 | 415.0K | $26M | +0.92% |
| Q1 2022 | 291.2K | $19M | +0.39% |
| Q4 2021 | 995.0K | $107M | +2.26% |
| Q3 2021 | 832.0K | $86M | +1.90% |
| Q2 2021 | 563.2K | $50M | +1.34% |
| Q1 2021 | 546.0K | $53M | +1.47% |
| Q4 2020 | 240.0K | $27M | +0.87% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Avidity Partners Management LP’s full portfolio or all institutional holders of 2655787D.